These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12000200)

  • 21. Introduction: the dual-action debate: does pharmacology matter?
    Thase ME
    J Clin Psychiatry; 2004; 65 Suppl 17():3-4. PubMed ID: 15600375
    [No Abstract]   [Full Text] [Related]  

  • 22. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can recovery from depression be achieved?
    Shelton RC; Tomarken AJ
    Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
    Blier P; de Montigny C
    Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
    Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
    MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
    Mochizucki D
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
    Jaracz J; Rybakowski J
    Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurochemical alterations of serotonergic neuronal systems in depression.
    Risch SC; Nemeroff CB
    J Clin Psychiatry; 1992 Oct; 53 Suppl():3-7. PubMed ID: 1331029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of new antidepressants.
    Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The symptoms, neurobiology, and current pharmacological treatment of depression.
    To SE; Zepf RA; Woods AG
    J Neurosci Nurs; 2005 Apr; 37(2):102-7. PubMed ID: 15902953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Painful physical symptoms in depression: a clinical challenge.
    Wise TN; Fishbain DA; Holder-Perkins V
    Pain Med; 2007 Sep; 8 Suppl 2():S75-82. PubMed ID: 17714118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.